Clinical and molecular features of FLT3 juxtamembrane domain missense mutations in acute myeloid leukaemia.

Saved in:
Bibliographic Details
Title: Clinical and molecular features of FLT3 juxtamembrane domain missense mutations in acute myeloid leukaemia.
Authors: Jensen CE; Divisions of Hematology and Oncology, Department of Internal Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.; Cecil G. Sheps Center for Health Services Research, University of North Carolina, Chapel Hill, North Carolina, USA., Montgomery ND; Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.; Tempus-RTP, Durham, North Carolina, USA., Galeotti J; Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA., Foster MC; Divisions of Hematology and Oncology, Department of Internal Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA., Zeidner JF; Divisions of Hematology and Oncology, Department of Internal Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
Source: Journal of cellular and molecular medicine [J Cell Mol Med] 2022 Dec; Vol. 26 (24), pp. 6079-6082. Date of Electronic Publication: 2022 Nov 28.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101083777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1582-4934 (Electronic) Linking ISSN: 15821838 NLM ISO Abbreviation: J Cell Mol Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1582-4934
DOI:10.1111/jcmm.17608